Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- PMID: 31042845
- DOI: 10.1056/NEJMc1902336
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Comment in
-
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Reply.N Engl J Med. 2019 May 2;380(18):e32. doi: 10.1056/NEJMc1902336. N Engl J Med. 2019. PMID: 31042847 No abstract available.
Comment on
-
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources